AIIMS Delhi to begin clinical trials for COVID-19 vaccine on 6-12 age group from Tuesday


New Delhi: In a move to test the efficacy of COVID-19 vaccines on children, the All India Institute Of Medical Sciences (AIIMS) Delhi will begin recruitment for clinical trials for the 6-12 age group from Tuesday (June 15, 2021).

The trial for Bharat Biotech’s Covaxin will also start from Tuesday. The clinical trials will try to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.

AIIMS Delhi also informed that the recruitment and clinical trial for a single dose of Covaxin for the 12-18 age group has been completed.



Leave a Reply

Your email address will not be published. Required fields are marked *